Single-cell multi-omics integration

Single-cell multi-omics integration describes a suite of computational methods used to harmonize information from multiple "omes" to jointly analyze biological phenomena. This approach allows researchers to discover intricate relationships between different chemical-physical modalities by drawing associations across various molecular layers simultaneously. Multi-omics integration approaches can be categorized into four broad categories: Early integration, intermediate integration, late integration methods. Multi-omics integration can enhance experimental robustness by providing independent sources of evidence to address hypotheses, leveraging modality-specific strengths to compensate for another's weaknesses through imputation, and offering cell-type clustering and visualizations that are more aligned with reality

Background The emergence of single-cell sequencing technologies has revolutionized our understanding of cellular heterogeneity, uncovering a nuanced landscape of cell types and their associations with biological processes. Single-cell omics technologies has extended beyond the transcriptome to profile diverse physical and chemical properties at single-cell resolution, including whole genomes/exomes, DNA methylation, chromatin accessibility, histone modifications, epitranscriptome (e.g., mRNAs, microRNAs, tRNAs, lncRNAs), proteome, phosphoproteome, metabolome, and more. There is an expanding repository of publicly available single-cell datasets, exemplified by growing databases such as the Human Cell Atlas Project (HCA), the Cancer Genome Atlas (TCGA), and the ENCODE project. With the increasing diversity in both available datasets and data types, multi-omics data integration and multimodal data analysis represent pivotal trajectories for the future of systems biology. Single-cell multi-omics integration can reveal underappreciated relationships between chemical-physical modalities, broaden our definition of cell states beyond single modality feature profiles, and provide independent evidence during analysis to support testing of biological hypotheses. However, the high dimensionality (features > observations), high degree of stochastic technical and biological variability, and sparsity of single-cell data (low molecule recovery efficiency) make computational integration a challenging problem. Furthermore, different solutions for multi-omics integration are available depending on factors such as whether the data is matched (simultaneous measurements derived from the same cell) or unmatched (measurements derived from different cells), whether cell-type annotations are available, or whether modality feature conversion is available, with different implementations tailored to suit the specific use case. As such, there are multiple approaches to single-cell data integration, each with a distinct use case, and each with its own set of advantages and disadvantages.

Approaches to multi-omics integration

Early integration Early integration is a method that concatenates (by binding rows and columns) two or more omics datasets into a single data matrix. Some advantages of early integration are that the approach is simple, highly interpretable, and capable of capturing relationships between features from different modalities. Early integration is primarily employed to merge datasets of the same datatype (e.g., integrating two distinct scRNA-seq datasets). This is because integrating datasets from different modalities may lead to a combined feature set with variable feature value ranges. For instance, expression data often spans a wider range compared to accessibility data, which typically ranges between values of 0 and 2. Early integration approaches produce data matrices with higher dimensionality compared to the original matrix. As such, dimensionality reduction methods such as feature selection and feature extraction are often necessary steps for downstream analysis. Feature selection involves retaining only the important variables from the original omic layers, while feature extraction transforms the original input features into combinations of the original features. The projection of high-dimensional data into a lower-dimensional space reduces noise and simplifies the dataset, resulting in easier data handling.

Intermediate integration Intermediate integration describes a class of approaches which aim to analyze multiple omic datasets simultaneously without the need for prior data transformation (as this occurs during data integration). Several examples of intermediate integration include similarity-based integration, joint dimension reduction, and statistical modelling.

Similarity-based integration Similarity-based integration aims to identify patterns across multi-omic datasets through the use of spectral clustering (eg. Spectrum and PC-MSC). Spectral clustering cluster cells based on either similarity matrices derived from a multi-omic dataset or graph fusion algorithms (eg. Seurat4) which construct graphs from individual omics layers and merges them into a single graph.

Joint dimension reduction Joint dimension reduction aims to reduce the complexity of multi-omics data by projecting observations onto a lower dimensional latent space such that the different omics layers can be analyzed together. Canonical correlation analysis (CCA), non-negative matrix factorization (NMF) and manifold alignment are popular approaches for joint dimensionality reduction. Tools that use CCA or its derivative sparse CCA, such as Seurat3 and bindSC identify linear relationships between datasets by identifying linear combinations of variables that maximize feature correlation. Tools which use NMF (eg. LIGER and coupledNMF) extract low-dimensional representations of high-dimensional data such that both shared and dataset-specific factors across the multiple omics datasets can be identified. Manifold alignment (eg., MATCHER and MAGAN) refers to an approach where low dimension representations of various multi-omic datasets are computed individually and then represented as a common latent space.

… excerpt ends here. Continue reading the full article.